Mark A. Tracy
Impact in
- Pharmaceutical Science top 2%
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Protein purification and stability 3
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 2
- Surgery 3
- Co-authors
- Henry R. Costantino (5 shared papers)Ying K. Tam (2 shared papers)Ismail M. Hafez (2 shared papers)Martin A. Maier (2 shared papers)Barbara L. Mui (2 shared papers)Thomas D. Madden (2 shared papers)Xinyao Du (2 shared papers)Muthiah Manoharan (2 shared papers)
- Journals
- Macromolecules (2 papers)Pharmaceutical Research (2 papers)AAPS PharmSciTech (1 paper)Angewandte Chemie International Edition (1 paper)Biomaterials (1 paper)
- Partner nations
- United StatesIrelandPuerto Rico
In The Last Decade
Mark A. Tracy
15 papers receiving 1.9k citations
Mark A. Tracy's Hit Papers
Peers
Comparison fields: 5 of 104
- Pharmaceutical Science 241
- Biomaterials 304
- Molecular Biology 1.3k
- Food Science 209
- Cancer Research 142
Countries citing papers authored by Mark A. Tracy
This map shows the geographic impact of Mark A. Tracy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Tracy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Tracy more than expected).
Fields of papers citing papers by Mark A. Tracy
This network shows the impact of papers produced by Mark A. Tracy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Tracy. The network helps show where Mark A. Tracy may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Tracy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo** Hit paper breakdown → | 2012 | 1027 |
| 2 | 2000 | 164 | |
| 3 | 2012 | 126 | |
| 4 | 2002 | 115 | |
| 5 | 1998 | 100 | |
| 6 | 2004 | 94 | |
| 7 | 2002 | 83 | |
| 8 | 1999 | 75 | |
| 9 | 2004 | 51 | |
| 10 | 1999 | 45 | |
| 11 | 1992 | 45 | |
| 12 | 1998 | 40 | |
| 13 | 1993 | 20 | |
| 14 | 1993 | 1 | |
| 15 | 2005 | 1 |
About Mark A. Tracy
Mark A. Tracy is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Pharmaceutical Science and Food Science, having authored 15 papers that have together received 2.0k indexed citations. Recurring topics across this work include Microencapsulation and Drying Processes (4 papers), Protein purification and stability (3 papers), Inhalation and Respiratory Drug Delivery (3 papers), RNA Interference and Gene Delivery (3 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Silk-based biomaterials and applications (2 papers), Advanced Drug Delivery Systems (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Pharmaceutical Science (241 citations), Biomaterials (304 citations), Molecular Biology (1.3k citations), Food Science (209 citations) and Cancer Research (142 citations). Mark A. Tracy has collaborated with scholars based in United States, Ireland and Puerto Rico. Frequent co-authors include Henry R. Costantino, Ying K. Tam, Ismail M. Hafez, Martin A. Maier, Barbara L. Mui, Thomas D. Madden, Xinyao Du, Muthiah Manoharan, Steven M. Ansell and Muthusamy Jayaraman. Their work appears in journals such as Macromolecules, Pharmaceutical Research, AAPS PharmSciTech, Angewandte Chemie International Edition and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.